Octagon Capital Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-455,000	Closed	-$4.83M	–	53
2024 Q1	$4.83M	Buy	455,000 +405,000	+810%	+$4.3M	0.58%	37
2023 Q4	$457K	Buy	+50,000	New	+$457K	0.07%	32